Analytics
Research insights and performance metrics
Total Simulations
1,978
+18.2% from last year
Avg Response Rate
54.3%
+5.2% improvement
FPGA Utilization
78.4%
Avg. daily usage
Compounds Tested
89
12.3% hit rate
Monthly Activity
Simulations, drug tests, and immunotherapy studies over time
Cancer Type Distribution
Research focus by cancer type
Response Rate Distribution
Distribution of predicted response rates across all simulations